Company Merck KGaA

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 09:06:55 2024-09-09 EDT			5-day change	1st Jan Change
169.32 ^EUR	+0.31%		-3.51%	+17.31%

09-03	Merck Gets EU Approval for Keytruda Cancer Therapy	DJ
08-29	Merck KGaA Doses First Patient in Late-stage Myasthenia Gravis Study	MT

Business description: Merck KGaA

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:

- solutions and products for scientific and biotechnological research (44.2%);

- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;

- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.

Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).

Number of employees: 62,176

Sales by Activity: Merck KGaA

Fiscal Period: December	2019	2020	2021	2022	2023
Life Science	6.88B	7.53B	9.05B	10.44B	9.36B
Healthcare	6.71B	6.64B	7.09B	7.84B	8.05B
Electronics	2.57B	3.38B	3.61B	4.01B	3.66B
Corporate and Other	-21M	-18M	-62M	-61M	-77M

See all business segments

Geographical breakdown of sales: Merck KGaA

Fiscal Period: December	2019	2020	2021	2022	2023
USA	4.1B	4.64B	5.25B	6.3B	5.91B
Other Europe	3.37B	3.55B	4.03B	4.52B	4.4B
Asia-Pacific (Excluding China)	3.25B	3.74B	4.09B	4.48B	4.18B
China	2.05B	2.22B	2.55B	2.82B	2.48B
Germany	1.48B	1.5B	1.66B	1.53B	1.42B
Latin America	965M	868M	947M	1.18B	1.27B
Middle East and Africa (MEA)	373M	361M	404M	516M	535M
Switzerland	389M	462M	529M	592M	512M
North America (Excluding USA)	182M	191M	225M	294M	287M

See all geographic segments

Managers: Merck KGaA

Director	Title	Age	Since
Belén Garijo López CEO	Chief Executive Officer	63	20-07-12
Helene von Roeder DFI	Director of Finance/CFO	54	19-04-25
Danny Bar-Zohar CTO	Chief Tech/Sci/R&D Officer	-	20-10-31
Laura Matz CTO	Chief Tech/Sci/R&D Officer	-	18-12-31
Constantin Fest IRC	Investor Relations Contact	-	-

See MERCK KGAA governance

Members of the board: Merck KGaA

Manager	Title	Age	Since
Christian Raabe BRD	Director/Board Member	-	-
Jürgen Glaser BRD	Director/Board Member	61	12-04-30
Helga Rübsamen-Schaeff BRD	Director/Board Member	75	14-05-08
Gabriele Eismann BRD	Director/Board Member	62	90-12-31
Dietmar Oeter BRD	Director/Board Member	58	94-12-31
Alexander Putz BRD	Director/Board Member	47	84-12-31
Sascha Held BRD	Director/Board Member	-	19-04-25
Michael Kleinemeier CHM	Chairman	67	19-04-25
Renate Koehler BRD	Director/Board Member	-	19-04-25
Anne Lange BRD	Director/Board Member	-	19-04-25

Composition of the Board of Directors

Shareholders: Merck KGaA

Name	Equities	%	Valuation
Massachusetts Financial Services Co. 5.058 %	6,536,955	5.058 %	1 173 M €
DWS Investment GmbH 2.946 %	3,806,894	2.946 %	683 M €
MFS International Singapore Pte Ltd. 1.675 %	2,165,068	1.675 %	388 M €
MFS International (UK) Ltd. 0.8563 %	1,106,758	0.8563 %	199 M €
Amundi Asset Management SA (Investment Management) 0.7697 %	994,715	0.7697 %	178 M €

Name	Equities	%	Valuation
Merck Family 100.00 %	305,535,626	100.00 %	54 817 M €

Name	Equities	%	Valuation
Manulife Investment Management Ltd. 0.0715 %	462,346	0.0715 %	17 M €
Henry James International Management, Inc. 0.0109 %	70,205	0.0109 %	3 M €
MAI Capital Management LLC 0.005729 %	37,020	0.005729 %	1 M €
Domini Impact Investments LLC 0.003374 %	21,800	0.003374 %	782 228 €
RhumbLine Advisers LP 0.001666 %	10,764	0.001666 %	386 234 €

List of MERCK KGAA shareholders

Holdings: Merck KGaA

Name	Equities	%	Valuation
MOONLAKE IMMUNOTHERAPEUTICS 4.43%	2,787,509	4.43%	130,427,546 $
PT MERCK TBK 86.65%	388,194,920	86.65%	96,450,910 $
VERA THERAPEUTICS, INC. 3.49%	1,913,501	3.49%	72,368,608 $
PRECIGEN, INC. 7.17%	20,647,152	7.17%	22,711,867 $

Company details: Merck KGaA

Merck KGaA

Frankfurter Strasse 250

64293, Darmstadt

+49 6151 72 0

http://www.merckgroup.com/de

Group companies: Merck KGaA

Name	Category and Sector
Ridgefield Holdco SARL
Sigma-Aldrich Pte Ltd. Sigma-Aldrich Pte Ltd. Chemicals: SpecialtyProcess Industries Part of Merck KGaA, Sigma-Aldrich Pte Ltd. is a Singaporean company that manufactures and supplies biochemical and organic chemical products. The company is located in Singapore.	Chemicals: Specialty
Merck SA Merck SA Pharmaceuticals: OtherHealth Technology Part of Merck KGaA, Merck SA is a Colombian company that manufactures pharmaceutical and chemical products. The company is based in Bogota, Colombia.	Pharmaceuticals: Other
Merck Capital Ltd.
Merck Invest SCS

See all subsidiaries

Specialty & Advanced Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
MERCK KGAA	+0.59%	-3.20%	+2.79%	-16.74%	81.49B
KYOWA KIRIN CO. LTD.	+1.69%	-0.82%	+24.44%	-18.90%	11.86B
YUHAN CORPORATION	-3.83%	-10.92%	+80.66%	+123.00%	7.12B
SK BIOPHARMACEUTICALS CO., LTD.	+0.10%	-9.48%	+27.11%	-10.64%	6.12B
BETTA PHARMACEUTICALS CO., LTD.	0.00%	+5.18%	-27.04%	-56.23%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-3.24%	-7.77%	+8.30%	+3.26%	1.98B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-3.08%	-8.26%	-14.90%	+46.70%	1.94B
SUPERNUS PHARMACEUTICALS, INC.	-1.57%	-3.75%	+10.62%	+25.19%	1.86B
VELOXIS PHARMACEUTICALS A/S	-.--%	-.--%	-	-	1.64B
INDIVIOR PLC	+1.29%	-14.32%	-55.93%	-18.73%	1.37B
Average	-0.81%	-4.27%	+6.23%	+8.55%	11.76B
Weighted average by Cap.	+0.23%	-4.35%	+9.73%	-6.75%